FDA BAA Industry Day 2022
Virtual Event
The U.S. Food and Drug Administration FDA will host an Industry Day on 6 December 2022 to discuss a Broad Agency Announcement (BAA) for state of the art advancements in
Advertisement
9 events found.
Government Hosted
APEC Medical Product Supply Chain Resilience Dialogue
USP Rockville 12601 Twinbrook Parkway, Rockville, MD, United States
Hybrid Event
FDA and United States Pharmacopeia (USP) are cosponsoring the Asia-Pacific Economic Cooperation (APEC) Medical Product Supply Chain Dialogue. This program aims to accelerate APEC and global efforts to strengthen the
FDA Public Meeting on Patient-Focused Drug Development for Long COVID
Virtual Event
The U.S. Food and Drug Administration (FDA) is hosting a virtual public meeting 25 April 2023 on Patient-Focused Drug Development for Long COVID. This meeting will provide FDA the opportunity
Test Development and Validation During the COVID-19 Public Health Emergency
Virtual Event
The U.S. Food and Drug Administration (FDA) will host a virtual town hall on 26 April 2023 for test developers to discuss the final guidances for the: Transition Plan for
Recombinant Protein-Based COVID-19 Vaccines Workshop
Virtual Event
The Biomedical Advanced Research and Development Authority (BARDA) and FDA will host a virtual workshop titled Recombinant Protein-Based COVID-19 Vaccines April 27, 2023, from 9:00 am EDT to 1:00 pm
Capturing Post-Approval Safety and Efficacy Data on Cell and Gene Therapy Products
Virtual Event
The FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) is hosting a virtual public listening meeting on 27 April 2023 to solicit input on methods
Collaborating on Culture in the New Era of Smarter Food Safety
Virtual Event
Live from the Food Safety Summit: Measure What You Treasure May 11, 2023, from 3:45 pm 5:00 pm ET The upcoming webinar will focus on the importance of assessing food
VRBPAC Meeting on Pfizer’s ABRYSVO Respiratory Syncytial Virus Vaccine
Virtual Event
Vaccines and Related Biological Products Advisory Committee May 18, 2023 Meeting Announcement On 18 May 2023, the committee will meet in open session to discuss and make recommendations on the
Update on Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR)
Virtual Event
FDA CDER Office of Pharmaceutical Quality is offering a five-hour webinar to discuss reporting requirements and expectations for Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR). The statutory